Question 1

What is osteosarcoma and how common is it in children?

Accepted Answer

Osteosarcoma is the most common type of primary bone cancer in children and adolescents. Approximately 400 new cases are diagnosed each year in the United States, primarily affecting children and young adults aged 10–20. It typically develops near the ends of long bones such as the femur or tibia.

Question 2

What is Team Arnav Foundation and what does it do?

Accepted Answer

Team Arnav Foundation is a 501(c)(3) nonprofit organization based in Allentown, Pennsylvania. Founded in 2019 by Dhruv Krishna in memory of his brother Arnav, who passed away from osteosarcoma in 2018, the Foundation raises funds to support pediatric osteosarcoma and sarcoma cancer research. It has raised over $100,000 since inception and has partnered with clinical-stage organizations such as OS Therapies to support Phase IIb clinical trials.

Question 3

How does Team Arnav Foundation use donated funds?

Accepted Answer

100% of funds raised by Team Arnav Foundation go directly toward pediatric osteosarcoma and sarcoma cancer research. The Foundation funds research partnerships, sponsors clinical trials, and supports scientists working to develop better therapies, improve cure rates, and reduce treatment toxicities for children with malignant bone tumors.

Question 4

Is Team Arnav Foundation a legitimate 501(c)(3) nonprofit?

Accepted Answer

Yes. Team Arnav Foundation is a registered 501(c)(3) tax-exempt nonprofit organization (EIN: 84-2401443), recognized by the IRS since July 2019. Donations are tax-deductible to the full extent permitted by law. Financial filings are publicly available through ProPublica Nonprofit Explorer and Candid (GuideStar).

Question 5

How can I get involved with Team Arnav Foundation?

Accepted Answer

You can support Team Arnav Foundation by donating at teamarnav.org/donate, volunteering, sponsoring events, or participating in the annual 5K run/walk held in the Lehigh Valley, Pennsylvania. The Foundation also accepts corporate sponsorships and in-kind contributions.

Question 6

Why has osteosarcoma treatment not improved in 40 years?

Accepted Answer

Standard osteosarcoma treatment has remained largely unchanged since the 1970s — a chemotherapy regimen followed by surgery. Osteosarcoma's rarity (about 400 U.S. cases per year) makes it difficult to attract large pharmaceutical investment, which is why nonprofit organizations like Team Arnav Foundation are critical in funding early-stage and translational research that larger institutions overlook.

Team Arnav Foundation

Fighting Pediatric Osteosarcoma

Events